scholarly journals A ginseng metabolite, compound K, induces autophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells

2013 ◽  
Vol 4 (8) ◽  
pp. e750-e750 ◽  
Author(s):  
A D Kim ◽  
K A Kang ◽  
H S Kim ◽  
D H Kim ◽  
Y H Choi ◽  
...  
2010 ◽  
Vol 286 (2) ◽  
pp. 1134-1146 ◽  
Author(s):  
Subash C. Gupta ◽  
Simone Reuter ◽  
Kanokkarn Phromnoi ◽  
Byoungduck Park ◽  
Padmanabhan S. Hema ◽  
...  

2016 ◽  
Vol 291 (32) ◽  
pp. 16925-16925 ◽  
Author(s):  
Subash C. Gupta ◽  
Simone Reuter ◽  
Kanokkarn Phromnoi ◽  
Byoungduck Park ◽  
Padmanabhan S. Hema ◽  
...  

2014 ◽  
Vol 7 (6) ◽  
pp. 1812-1818 ◽  
Author(s):  
SEO-YOUNG KWAK ◽  
YOUN KYOUNG JEONG ◽  
BU-YEON KIM ◽  
JI YOUNG LEE ◽  
HYUN-JOO AHN ◽  
...  

2019 ◽  
Vol 97 (12) ◽  
pp. 1176-1184 ◽  
Author(s):  
Hassan Abbaszadeh ◽  
Armita Valizadeh ◽  
Masoud Mahdavinia ◽  
Ali Teimoori ◽  
Mohammad Hassan Pipelzadeh ◽  
...  

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a promising anticancer cytokine with minimal toxicity towards normal cells. Nevertheless, most primary cancers are often intrinsically TRAIL-resistant or can acquire resistance after TRAIL therapy. This study aimed to investigate the inhibitory effect of co-treatment of 3-bromopyruvate (3-BP) as a potent anticancer agent with TRAIL on colon cancer cells (HT-29). The results of present study indicated that combined treatment with 3-BP and TRAIL inhibited the proliferation of HT-29 cells to a greater extent (88.4%) compared with 3-BP (54%) or TRAIL (11%) treatment alone. In contrast, the combination of 3-BP and TRAIL had no significant inhibitory effect on the proliferation of normal cells (HEK-293) (8.4%). At a cellular mechanistic level, the present study showed that 3-BP sensitized human colon cancer cells to TRAIL-induced apoptosis via reactive oxygen species generation, upregulation of Bax, downregulation of Bcl-2 and survivin, release of cytochrome c into the cytosol, and activation of caspase-3. In normal cells, 3-BP, TRAIL, or combination of both had no significant effect on the reactive oxygen species levels, release of cytochrome c, and caspase-3 activity. Therefore, the combination of 3-BP and TRAIL can be a promising therapeutic strategy for treatment of colon cancer.


Sign in / Sign up

Export Citation Format

Share Document